awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36305803-EA5646C6-93C9-449C-A3C2-966DAB9BB488
Q36305803-EA5646C6-93C9-449C-A3C2-966DAB9BB488
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36305803-EA5646C6-93C9-449C-A3C2-966DAB9BB488
Maintenance Therapies in Indolent Lymphomas: should Recent Data Change the Standard of Care?
P2860
Q36305803-EA5646C6-93C9-449C-A3C2-966DAB9BB488
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36305803-EA5646C6-93C9-449C-A3C2-966DAB9BB488
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91769991b9fbe5c8e3cf33dc81649b34fa202714
P2860
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.